DD209455A5 - Verfahren zur herstellung von ascorbinsaeureethern - Google Patents
Verfahren zur herstellung von ascorbinsaeureethern Download PDFInfo
- Publication number
- DD209455A5 DD209455A5 DD83247195A DD24719583A DD209455A5 DD 209455 A5 DD209455 A5 DD 209455A5 DD 83247195 A DD83247195 A DD 83247195A DD 24719583 A DD24719583 A DD 24719583A DD 209455 A5 DD209455 A5 DD 209455A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- ascorbic acid
- alkyl
- compound
- formula
- acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/32—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/62—Three oxygen atoms, e.g. ascorbic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33934482A | 1982-01-15 | 1982-01-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DD209455A5 true DD209455A5 (de) | 1984-05-09 |
Family
ID=23328588
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD83247195A DD209455A5 (de) | 1982-01-15 | 1983-01-12 | Verfahren zur herstellung von ascorbinsaeureethern |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP0086554A1 (fr) |
| JP (1) | JPS58131978A (fr) |
| KR (1) | KR840003247A (fr) |
| AU (1) | AU1035183A (fr) |
| CA (1) | CA1181078A (fr) |
| DD (1) | DD209455A5 (fr) |
| DK (1) | DK14283A (fr) |
| ES (2) | ES8403118A1 (fr) |
| FI (1) | FI830078L (fr) |
| GB (1) | GB2114571A (fr) |
| GR (1) | GR77897B (fr) |
| IL (1) | IL67646A0 (fr) |
| PL (1) | PL240125A1 (fr) |
| PT (1) | PT76083B (fr) |
| RO (1) | RO86439B (fr) |
| ZA (1) | ZA83173B (fr) |
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4552895A (en) * | 1983-03-14 | 1985-11-12 | Eli Lilly And Company | Furo[3,2-b]furan-2-(3H)-ones |
| JPS6058973A (ja) * | 1983-09-13 | 1985-04-05 | Mitsubishi Yuka Yakuhin Kk | γ−プチロラクトン誘導体及びそれを有効成分とする免疫調節剤 |
| JPS60130582A (ja) * | 1983-12-19 | 1985-07-12 | Takeda Chem Ind Ltd | 食品用酸化防止剤，アスコルビン酸誘導体およびその製造法 |
| WO1986006720A1 (fr) * | 1985-05-17 | 1986-11-20 | Takeda Chemical Industries, Ltd. | Derives d'acide ascorbique, production desdits derives et preparation pharmaceutique pouvant en resulter |
| WO1986007592A1 (fr) * | 1985-06-18 | 1986-12-31 | Takeda Chemical Industries, Ltd. | Derives d'acide ascorbique, leur procede de preparation, et preparations les contenant |
| JPS60139619A (ja) * | 1983-12-27 | 1985-07-24 | Mutsuyuki Kochi | Ｏ−ベンジリデン−アスコルビン酸又はその塩よりなる抗腫瘍剤 |
| JP2515556B2 (ja) * | 1986-08-29 | 1996-07-10 | 武田薬品工業株式会社 | ヒドロキシブテノライド誘導体およびその製造法 |
| JPH0730066B2 (ja) * | 1988-03-09 | 1995-04-05 | 株式会社日本ハイポックス | アスコルビン酸誘導体及びアスコルビン酸誘導体からなる抗酸化剤 |
| JP2752080B2 (ja) * | 1988-03-09 | 1998-05-18 | 株式会社日本ハイポックス | アスコルビン酸誘導体及びその製造方法並びにアスコルビン酸誘導体からなる抗酸化剤 |
| ATE150750T1 (de) | 1988-09-01 | 1997-04-15 | Takeda Chemical Industries Ltd | Fumagillol-derivate |
| DE69024193T2 (de) * | 1989-09-11 | 1996-05-30 | Nippon Hypox Lab Inc | Ascorbinsäure-derivate |
| US5095126A (en) * | 1990-01-12 | 1992-03-10 | Ohio State University Research Foundation | Efficient synthesis for optically pure stereogenically labile 4-substituted-2-hydroxytetronic acids |
| ATE125814T1 (de) * | 1990-03-07 | 1995-08-15 | Hoffmann La Roche | Verfahren zur herstellung von derivaten der ascorbinsäure. |
| EP0446539A1 (fr) * | 1990-03-16 | 1991-09-18 | Merrell Dow Pharmaceuticals Inc. | Dérivé de l'acide ascorbique |
| US5270336A (en) * | 1990-03-16 | 1993-12-14 | Merrell Dow Pharmaceuticals Inc. | Ascorbic acid derivatives |
| JPH0429989A (ja) * | 1990-05-24 | 1992-01-31 | Nisshin Flour Milling Co Ltd | Ｌ―アスコルビン酸誘導体の製造法 |
| GB9026114D0 (en) * | 1990-11-30 | 1991-01-16 | Norsk Hydro As | New compounds |
| GB9201274D0 (en) * | 1992-01-21 | 1992-03-11 | Norsk Hydro As | New compounds |
| GB9201275D0 (en) * | 1992-01-21 | 1992-03-11 | Norsk Hydro As | New compounds |
| TW325997B (en) * | 1993-02-02 | 1998-02-01 | Senju Pharma Co | Pharmaceutical composition for preventing and treating retinal diseases |
| RU2126398C1 (ru) * | 1993-02-05 | 1999-02-20 | Плива, Фармацеутска, Кемийска, Прехрамбена и Козметичка Индустрия Дионичко Друштво Загреб | Производные аминоаскорбиновой кислоты, способы их получения и производные галоидаскорбиновой кислоты |
| US6228879B1 (en) | 1997-10-16 | 2001-05-08 | The Children's Medical Center | Methods and compositions for inhibition of angiogenesis |
| US5629327A (en) * | 1993-03-01 | 1997-05-13 | Childrens Hospital Medical Center Corp. | Methods and compositions for inhibition of angiogenesis |
| US6114355A (en) * | 1993-03-01 | 2000-09-05 | D'amato; Robert | Methods and compositions for inhibition of angiogenesis |
| US6908910B2 (en) | 1993-08-06 | 2005-06-21 | The Children's Medical Center Corporation | Estrogenic compounds as anti-mitotic agents |
| US5504074A (en) | 1993-08-06 | 1996-04-02 | Children's Medical Center Corporation | Estrogenic compounds as anti-angiogenic agents |
| EP1586322B1 (fr) | 1996-11-05 | 2008-08-20 | The Children's Medical Center Corporation | Compositions contenant de thalidomide et de dexamethasone pour le traitement du cancer |
| EP0875246A1 (fr) * | 1997-04-04 | 1998-11-04 | Showa Denko Kabushiki Kaisha | Préparation pharmaceutique de dérivés d'acide ascorbique pour le traitement du cancer |
| BR9909168A (pt) * | 1998-03-27 | 2000-12-05 | Lg Chemical Ltd | Derivados de ácido ascórbico polietoxilados como anti-oxidantes e processo para preparação dos mesmo |
| US6673828B1 (en) | 1998-05-11 | 2004-01-06 | Children's Medical Center Corporation | Analogs of 2-Phthalimidinoglutaric acid |
| US7087592B1 (en) | 1999-08-23 | 2006-08-08 | Entre Med, Inc. | Compositions comprising purified 2-methoxyestradiol and methods of producing same |
| AU2001230554A1 (en) * | 2000-02-01 | 2001-08-14 | Mutsuyuki Kochi | Neovascularization inhibitory compositions and method of inhibiting neovascularization |
| ATE298240T1 (de) * | 2000-03-31 | 2005-07-15 | Angiogene Pharm Ltd | Getrennte dosis therapien mit gefässschädigender aktivität |
| DE60118625T2 (de) * | 2001-07-26 | 2007-02-22 | Tagra Biotechnologies Ltd. | Stabilisierte ascorbinsäure -3- phosphat- derivate |
| KR100971599B1 (ko) | 2002-05-15 | 2010-07-20 | 비에이취엔 가부시끼가이샤 | 혈관 관련 질환의 예방 또는 치료를 위한 조성물 |
| EP1939192A1 (fr) * | 2006-12-28 | 2008-07-02 | Neuropharma S.A. | Dérivés de cyclopentanone, procédé pour la synthése et utilisation de ceux-ci |
| FR2955493B1 (fr) * | 2010-01-28 | 2012-02-24 | Oreal | Utilisation de derives d'acide ascorbique en coloration des fibres keratiniques humaines, composition les comprenant, procede de coloration et dispositif |
| JP5602456B2 (ja) * | 2010-02-24 | 2014-10-08 | 日本精化株式会社 | アスコルビン酸誘導体 |
| WO2015048121A1 (fr) * | 2013-09-25 | 2015-04-02 | University Of Florida Research Foundation, Inc. | Promédicaments de la vitamine c et leurs utilisations |
| US10105407B2 (en) * | 2015-06-09 | 2018-10-23 | John P. Crow, JR. | Methods of extraction of nitrosylated or nitrated derivatives of ascorbic acid from myriciaria dubia and methods of synthesis thereof |
| ES2843724T3 (es) | 2015-11-30 | 2021-07-20 | Inst Nat Sante Rech Med | Antagonistas de NMDAR para el tratamiento de la angiogénesis tumoral |
-
1983
- 1983-01-10 FI FI830078A patent/FI830078L/fi not_active Application Discontinuation
- 1983-01-10 IL IL67646A patent/IL67646A0/xx unknown
- 1983-01-10 RO RO109663A patent/RO86439B/ro unknown
- 1983-01-11 PT PT76083A patent/PT76083B/pt unknown
- 1983-01-11 ZA ZA83173A patent/ZA83173B/xx unknown
- 1983-01-11 CA CA000419220A patent/CA1181078A/fr not_active Expired
- 1983-01-12 PL PL24012583A patent/PL240125A1/xx unknown
- 1983-01-12 DD DD83247195A patent/DD209455A5/de unknown
- 1983-01-13 GR GR70253A patent/GR77897B/el unknown
- 1983-01-13 JP JP58005144A patent/JPS58131978A/ja active Pending
- 1983-01-13 GB GB08300907A patent/GB2114571A/en not_active Withdrawn
- 1983-01-13 EP EP83300174A patent/EP0086554A1/fr not_active Ceased
- 1983-01-13 ES ES518968A patent/ES8403118A1/es not_active Expired
- 1983-01-13 AU AU10351/83A patent/AU1035183A/en not_active Abandoned
- 1983-01-14 KR KR1019830000115A patent/KR840003247A/ko not_active Ceased
- 1983-01-14 DK DK14283A patent/DK14283A/da not_active Application Discontinuation
- 1983-08-30 ES ES525239A patent/ES8502698A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| PT76083B (en) | 1986-01-09 |
| AU1035183A (en) | 1983-07-21 |
| JPS58131978A (ja) | 1983-08-06 |
| DK14283D0 (da) | 1983-01-14 |
| FI830078A0 (fi) | 1983-01-10 |
| ES518968A0 (es) | 1984-03-01 |
| GR77897B (fr) | 1984-09-25 |
| ES8403118A1 (es) | 1984-03-01 |
| FI830078A7 (fi) | 1983-07-16 |
| GB2114571A (en) | 1983-08-24 |
| RO86439A (fr) | 1985-03-15 |
| ES525239A0 (es) | 1985-01-16 |
| ZA83173B (en) | 1984-08-29 |
| PL240125A1 (en) | 1984-04-24 |
| PT76083A (en) | 1983-02-01 |
| FI830078L (fi) | 1983-07-16 |
| DK14283A (da) | 1983-07-16 |
| KR840003247A (ko) | 1984-08-20 |
| IL67646A0 (en) | 1983-05-15 |
| RO86439B (ro) | 1985-03-31 |
| GB8300907D0 (en) | 1983-02-16 |
| EP0086554A1 (fr) | 1983-08-24 |
| ES8502698A1 (es) | 1985-01-16 |
| CA1181078A (fr) | 1985-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DD209455A5 (de) | Verfahren zur herstellung von ascorbinsaeureethern | |
| DE2915037C3 (de) | Neue N-substituierte Moranolinderivate | |
| US4552888A (en) | Ascorbic acid ethers in angiogene | |
| EP0247320A2 (fr) | 5-Arylalkyl-4-alkoxy-2(5H)-furanones, produits intermédiaires et leur procédé de préparation, ainsi que leur application comme agents à activité thérapeutique | |
| DE2923368A1 (de) | Neue 5-fluor-( beta -uridin oder 2'-desoxy- beta -uridin)-derivate, verfahren zur herstellung derselben und carcinostatische mittel mit einem gehalt derselben | |
| DE69811500T2 (de) | Kristallmodifikation von 1-(2,6-difluorbenzyl)-1h-1,2,3-triazol-4-carbonsäureamid und seine verwendung als antiepileptikum | |
| DE2839388A1 (de) | Imidazolylvinylaether und deren verwendung | |
| DE60131416T2 (de) | Chirale fluochinolon-argininsalzformen | |
| DE69623760T2 (de) | Kaliumionen-kanal-blocker | |
| DE3033895A1 (de) | Psoralene, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate | |
| DE69102477T2 (de) | 3-Aminochroman-Derivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen. | |
| CH643830A5 (de) | Bis-moranolin-derivate. | |
| DE69500329T2 (de) | Neue Triazol-Verbindung mit fungizider Wirkung, deren Herstellung und Verwendung | |
| DE3438244C2 (fr) | ||
| DE3021169A1 (de) | Pivaloyloxymethyl-2-propylpentanoat, verfahren zu seiner herstellung und diese verbindung enthaltende arzneimittel | |
| DE68905361T2 (de) | Trienische Derivate mit chromenischer Struktur, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammenstellungen. | |
| DE2909646B1 (de) | N-Alkenylmoranolinderivate | |
| DE2650231A1 (de) | Neue imidazolverbindungen, verfahren zu ihrer herstellung und diese enthaltende arzneimittel | |
| DE69809564T2 (de) | 2- 4-[4-(4,5-dichlor-2-methylimidazol-1-yl)butyl]piperazin-1-yl -5-fluorpyrimidin, seine herstellung und therapeutische verwendung | |
| DE2932357A1 (de) | Crotonamidderivate und sie enthaltende carcinostatische arzneimittel | |
| DE1545581A1 (de) | Neue Penicillinaldehyde und Verfahren zu deren Herstellung | |
| DE1645901C3 (de) | gamma-(4-Alkylp!peridino)-p-fluorbutyrophenone und Verfahren zu ihrer Herstellung | |
| DE3146867A1 (de) | Aether von substituierten hydroxymethylpyrazinen | |
| CH687001A5 (de) | Pharmazeutisches Praeparat zur Modulierung der Immunreaktion. | |
| DE1795125C (de) | Chinolinderivate, ein Verfahren zu ihrer Herstellung und Arzneimittel |